Description

There are about two dozen FDA-approved antidepressant agents on the market, with demonstrated efficacy and safety. With the growing number of available therapeutic options, the psychiatric field is increasingly focused on addressing specific treatments that are best suited to certain patients and how to maximize the efficacy of these treatments while minimizing adverse effects. This simulation will teach participants the differential efficacy and safety of the various therapies as well as improved characterization of populations that may be more vulnerable to depression and/or more likely to respond to a particular therapy. An improved understanding of the efficacy and side effects of the medication will allow physicians to address patient attitudes towards antidepressants and improve patient ability and confidence in managing side effects, both of which are associated with improved long-term adherence to pharmacotherapy.

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Demonstrate the ability to manage and implement treatment strategies that are best suited for specific patient populations.

Target Audience

Psychiatrists, Primary Care Physicians, Nurse Practitioners, and Physician Assistants

Faculty

  • Jonathan E. Alpert, MD, PhD
    Associate Chief of Psychiatry for Clinical Services, MGH
    Associate Director, Depression Clinical and Research Program, MGH
    Joyce R. Tedlow Associate Professor of Psychiatry, Harvard Medical School
  • Tristan L Gorrindo, MD
    Co-Director, MGH Postgraduate Medical Education
    Instructor in Psychiatry, Harvard Medical School

CME Information

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital, Massachusetts General Hospital Academy and Reed Medical Education. McLean Hospital is accredited by the ACCME to provide continuing medical education (CME) for physicians.

Credit Designation
McLean Hospital designates this continuing medical educational activity for a maximum of 1 AMA PRA Category 1 Credits(TM). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). McLean Hospital has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

Planners

The following planners of this activity have indicated that neither they nor their families have a significant financial interest or affiliation with the manufacturer of any commercial products or provider of commercial services:

Robert J. Birnbaum, MD, PhD: Planner

John A. Fromson, MD: Planner, reviewer

Anan Nathif, EdM: Planner

Tristan Gorrindo, MD: Planner

Hardware/Software Specifications: 

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements:
Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh:
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

Speakers

 

The following speakers and/or planners have reported receiving something of value from a company whose product may be germane to the content of their presentations:

Jonathan E. Alpert, MD, PhD

Research Support

Abbott Labs, Alkermes, Lichtwer Pharma GmbH, Lorex Pharmaceuticals, Aspect Medical Systems, Astra-Zeneca Pharmaceuticals, Bristol-Myers Squibb, Cephalon, Cyberonics, Eli Lilly & Co., Forest Pharmaceuticals, Pfizer Inc., Pharmavite, Roche Laboratories, Sanofi/Synthelabo, Solvay Pharmaceuticals, Wyeth-Ayerst Labs, GlaxoSmithKline, J&J Pharmaceuticals, Novartis, Organon Inc., and PamLab LLC.

Speaking/Honoraria

Eli Lilly & Co., Janssen Pharmaceuticals, and Organon Inc..

Advisory/Consulting

Pharmavite, Eli Lilly & Co., and PamLab LLC.

Last updated: 7/27/2010

 

Tristan L Gorrindo, MD

Dr. Gorrindo has indicated that neither he nor any member of his immediate family has a significant financial interest or affiliation with the manufacturer of a commercial product or provider of a commercial service.

Last updated: 1/5/2012

Supporters

Location

online